Genetic discrimination by Australian insurance companies: a survey of consumer experiences
Open Access
- 8 July 2019
- journal article
- research article
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 28 (1) , 108-113
Abstract
We report previously undocumented evidence of genetic discrimination by Australian insurance companies, obtained through direct consumer reports. We surveyed 174 consumers with cancer-predisposing variants, recruited by cancer organisations Lynch Syndrome Australia and Pink Hope. Questions related to experiences accessing risk-rated insurance after genetic testing. Results indicate that both legal (permitted under current regulation) and illegal discrimination is occurring. Although some respondents had not applied for risk-rated insurance, or had insurance in place before genetic testing (n = 100), those seeking new policies (n = 74) commonly experienced difficulties obtaining insurance (86%, 64/74). Of those experiencing difficulties, 50% (32/64) had no prior history or symptoms of cancer, and had undertaken risk reduction through surveillance and/or preventative surgery. Seventy-seven percent (49/64) reported difficulties related to life insurance. Follow-up telephone interviews with four respondents further described cases of apparent illegal breaches. All reports of discrimination identified were, to our knowledge, previously unreported in the literature. The number of cases suggests a systemic problem with the Australian life insurance industry. We support calls for government oversight of the inherently conflicted model of industry self-regulation in Australia, and an immediate ban on the use of genetic test results in insurance underwriting.Keywords
This publication has 18 references indexed in Scilit:
- MRI breast screening in high-risk women: cancer detection and survival analysisBreast Cancer Research and Treatment, 2014
- Life insurance and genetic test results: a mutation carrier's fight to achieve full coverMedical Journal of Australia, 2013
- Genetic Discrimination: International PerspectivesAnnual Review of Genomics and Human Genetics, 2012
- Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trialThe Lancet, 2011
- Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and MortalityJAMA, 2010
- Verification of consumers' experiences and perceptions of genetic discrimination and its impact on utilization of genetic testingGenetics in Medicine, 2009
- The Use of Legal Remedies in Australia for Pursuing Allegations of Genetic Discrimination: Findings of an Empirical StudyInternational Journal of Discrimination and the Law, 2007
- Investigating genetic discrimination in the Australian life insurance sector: the use of genetic test results in underwriting, 1999-2003.2007
- Prophylactic Surgery to Reduce the Risk of Gynecologic Cancers in the Lynch SyndromeNew England Journal of Medicine, 2006
- Genetic testing, adverse selection, and the demand for life insuranceAmerican Journal of Medical Genetics, 2000